What pre‑operative management is recommended for a patient scheduled for sacrocolpopexy in 12 days, including control of hip and buttock muscle spasms, medication adjustments, and required pre‑operative labs?

Pre-operative Management for Sacrocolpopexy in 12 Days

For a patient scheduled for sacrocolpopexy in 12 days, implement multimodal pre-operative analgesia with acetaminophen and NSAIDs (or COX-2 inhibitors), address muscle spasms with appropriate muscle relaxants continued through surgery, and obtain standard pre-operative labs based on patient comorbidities rather than routine screening.

Muscle Spasm Management

Continue current muscle relaxants through the day of surgery to prevent withdrawal symptoms and optimize surgical conditions 1. The specific approach depends on the agent:

• Tizanidine: Continue through surgery including day of procedure. Abrupt discontinuation risks withdrawal with rebound tachycardia, hypertension, and increased muscle tone 1

• Cyclobenzaprine or Metaxalone: Hold on day of operation only 1

• Carisoprodol: If the patient is taking this, ideally taper off over 4-9 days before surgery due to its controlled substance status and withdrawal risk. With only 12 days available, begin tapering immediately or switch to an alternative agent 1

For hip and buttock spasms specifically, consider whether botulinum toxin injections could be beneficial pre-operatively, though this is typically reserved for severe spasticity cases 2.

Pre-operative Medication Optimization

Multimodal Analgesia Initiation

Begin oral multimodal analgesia 1-2 days before surgery 3:

• Acetaminophen: Dose-adjusted for age and renal function
• NSAID or COX-2 inhibitor: Dose-adjusted for age and renal function
• Avoid gabapentinoids pre-operatively: Despite opioid-sparing effects, they cause sedation, dizziness, and visual disturbances that outweigh benefits for this procedure 3

Medications to Avoid

• Benzodiazepines: Avoid pre-operative anxiolytics, especially in elderly patients, due to risk of cognitive impairment, delirium, and falls 3
• Routine pre-medications: Patient education reduces anxiety adequately without pharmacologic anxiolysis 3

Special Considerations

If patient is on buprenorphine (though not mentioned in your case): Continue if dose ≤12 mg sublingual daily; taper to 12 mg if higher dose 2-3 days before surgery 4

If patient is on chronic opioids: Continue through surgery with multimodal analgesia as cornerstone 4

Pre-operative Laboratory Testing

No routine pre-operative labs are recommended 5. Instead, order selective tests based on:

• Medical comorbidities identified in history and physical: Cardiac disease, renal dysfunction, diabetes, coagulopathy
• Current medications: Anticoagulants, diuretics, medications affecting electrolytes
• Surgical invasiveness: Sacrocolpopexy is moderate invasiveness

Typical selective labs might include:

• CBC if history of anemia or bleeding disorders
• Basic metabolic panel if renal disease, diabetes, or on diuretics
• Coagulation studies only if on anticoagulants or bleeding history
• Pregnancy test if applicable

Routine screening labs in asymptomatic patients do not improve perioperative outcomes 5.

Additional Pre-operative Preparations

Patient Education and Optimization

• Functional status assessment: Poor pre-operative functional status associates with longer hospital stays after sacrocolpopexy 6
• Pain expectations: Educate on expected post-operative pain trajectory and multimodal pain management plan 7
• Bowel preparation: Not routinely indicated for sacrocolpopexy based on available evidence 6

Antimicrobial Prophylaxis Planning

• Single dose IV antibiotics: Administer within 60 minutes of incision (cephalosporin + metronidazole typical) 3
• No benefit to multiple doses 3

Anesthesia Considerations

For laparoscopic sacrocolpopexy, epidural analgesia in addition to spinal anesthesia has been shown to lower post-operative pain levels throughout the hospital stay 6. Discuss this option with anesthesia during pre-operative evaluation.

Critical Pitfalls to Avoid

1. Do not abruptly stop muscle relaxants: Particularly tizanidine and carisoprodol risk severe withdrawal
2. Do not order routine labs: Only selective testing based on clinical indicators
3. Do not use gabapentinoids pre-operatively: Sedation interferes with early mobilization despite opioid-sparing effects
4. Do not use benzodiazepines for anxiety: Patient education is equally effective without cognitive risks

Timeline for 12-Day Pre-operative Period

• Day 1-2: Complete pre-operative evaluation, order selective labs if indicated
• Day 3-10: If on carisoprodol, begin taper; optimize functional status
• Day 10-11: Begin acetaminophen and NSAID/COX-2 inhibitor
• Day 12 (surgery day): Continue muscle relaxants (except cyclobenzaprine/metaxalone), continue multimodal analgesia